State
of New York
|
1-10113
|
11-0853640
|
(State
of Other Jurisdiction
|
(Commission
File Number)
|
(I.R.S.
Employer
|
of
Incorporation)
|
Identification
Number)
|
o |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17CFR240.14d- 2(b))
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR
240.13e- 4(c))
|
Exhibit Number
|
Description
|
|
99.1
|
Press
Release dated July 30, 2008 Announcing Financial Results for the
Second
Quarter of 2008
|
ACURA
PHARMACEUTICALS, INC.
|
|
By:
|
/s/
Peter A. Clemens
|
Peter
A. Clemens
|
|
Senior
Vice President & Chief Financial
Officer
|
Exhibit Number
|
Description
|
|
99.1
|
Press
Release dated July 30, 2008 Announcing Financial Results for the
Second
Quarter of 2008
|